News & Events

In this study, which was published in the journal Frontiers in Immunology on September 30th, researchers used sequencing to characterize the immune system of patients who survive from COVID-19 infection from symptom onset through recovery. Importantly, they also identified a potent biomarker for predicting disease progression. Follow-up studies could lead…

Watch the presentation now Join us at a new Virtual Summit, hosted by Samba Scientific. iRepertoire’s own Director of R&D and Operations Manager Miranda Byrne-Steele will present on September 23rd, followed by a live Q&A session. Sign up now for this new free summit on the latest advances in translational…

State-of-the-art Infectious Disease Response In this presentation, our founder, Dr. Jian Han, discusses how iRepertoire’s technology has evolved from lessons learned through multiple epidemics to identify helpful antibodies with first-rate specificity, now using single-cell sequencing. Gain a personal overview of our pathway as a company, and an insider introduction to…

Learn about our progress developing antibody-based therapies for SARS-CoV-2 in this presentation from Dr. Miranda Byrne-Steele, featured at Beckman Coulter Life Sciences’ COVID-19 Research Symposium. COVID-19 is very much a part of our lives today. Without herd immunity, we will need stopgap treatments to help patients fight SARS-CoV-2. We are…

iRepertoire is working with iCubate, our sister company in the Hudson Alpha Institute, to develop innovative solutions for combating the Coronavirus. On one side of the intervention strategy, iCubate is distributing diagnostic tests based on the same technology that powers the iR-Flex automation system. On the other side, iRepertoire will…

One of the biggest challenges in addressing COVID-19 has been the variability in the degree and type of symptoms that infected individuals have presented. Though it’s still unclear how to treat COVID-19 most effectively, one thing is certain: not all patients will require the same form or level of treatment.…

We are actively conducting research on COVID-19 with the goal of developing an antibody-based treatment. Additionally, we are maintaining limited laboratory operations in order to better serve our customers and collaborators who are doing their utmost in the fight against the pandemic. A message from our Founder, Dr. Jian Han…

Labroots webinar featuring Dr. Miranda Byrne-Steele highlights iRepertoire’s newest technologies, dam-PCR and iPair. iPair is iRepertoire’s single cell repertoire sequencing service. In the webinar, Miranda explains how iPair retains the physical cognate pairing of B and T cell receptor chains. She also describes how iPair helps researchers probe the immune…

We’re excited to introduce our new CEO, Dennis Grimaud. Dennis Grimaud brings with him over 40 years of experience in the healthcare industry. Dennis has served as CEO for six different life science-related companies with focuses including business management, diagnostics, and disease management. He has also founded several companies and…

At the 2019 Gold Lab Symposium, iRertoire’s founder, Dr. Jian Han, explains what we can learn from a database of several billion B and T cell receptor sequences. The Gold Lab Symposium is an annual event that brings together leaders in their respective scientific fields that are committed to improving…